Jordyn Hanover

Clinical Trial Operations

Role: Senior Clinical Project Manager at Apollo Therapeutics
Location: Quincy, MA, US
LinkedIn followers: 500 followers

Research & DevelopmentView LinkedIn profile

About Jordyn Hanover

Experienced in clinical trial activities with a demonstrated history of working on trials from both the industry and academia perspectives. Skilled in Clinical Research Experience, Good Clinical Practices, and Scientific Communications. Strong clinical operations professional with a Bachelor of Science (BS) focused in Behavioral Neuroscience from Northeastern University and a Masters of Science (MSc) in Regulatory Affairs from Northeastern University.

Experience

Senior Clinical Project Manager
Apollo Therapeutics
Oct 2024 — Present

Education

Northeastern University
Master of Science - MS, Regulatory Affairs
Northeastern University
Bachelor of Science (BS), Behavioral Neuroscience

Skills

Wiki Markup
Statistics
Molecular Genetics
Adobe Connect
Customer Service
Sharepoint
Peer Mentoring
Behavioral Neuroscience
Wiki Development
Scientific Writing
Organization of Events
Audacity
Event Planning
Microsoft Word
Adobe Presenter
Survey Management
Clinical Research
Data Analysis
Leadership
Psychology
Videoscribe
Research

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@apollotherapeutics.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Apollo Therapeutics

Biotechnology Research · 66 employees

Apollo Therapeutics is a biopharmaceutical company rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough discoveries. Through deep relationships with world-leading universities and scientists, the company identifies programs with strong biological hypotheses and potential to become meaningful new treatment options. Apollo’s portfolio-based model combines a centralized team of drug development ‘architects’ and subject matter experts who are able to rigorously evaluate therapeutic programs in an objective, data-driven manner – prioritizing critical experiments to de-risk programs early. This capital efficiency allows Apollo to focus on scaling a robust and potentially transformative pipeline, with over 15 therapeutic programs in development today across oncology, major inflammatory disorders and rare disease. Apollo’s innovative model was created in late 2015 by three world-leading universities Cambridge, Imperial College London and University College London in partnership with AstraZeneca, GlaxoSmithKline and Johnson & Johnson Innovation. There is significant opportunity ahead of us to bring new treatments to market as our lead programs move into clinical development. We will look to build on our existing collaborations, foster new relationships with additional top academics around the world and in-license drug candidates from new partners. Apollo is funded by Patient Square Capital, Rock Springs Capital, Reimagined Ventures and UCL Technology Fund. We are expanding our operations in Cambridge, UK and Boston, USA. For more information, please visit our website at

apollotherapeutics.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.